Gene · 3981
Papers3,259
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 3,259
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DNA-PK promotes DNA end resection at DNA double strand breaks in G0 cells. | Elife | 2022 | 35575473 | PubTator, text mining | PubMed |
| Development of a Novel Reference Material for Tumor Mutational Burden Measurement Based on CRISPR/Cas9 Technology. | Front Oncol | 2022 | 35574377 | PubTator, text mining | PubMed |
| Targeting PARP1 to Enhance Anticancer Checkpoint Immunotherapy Response: Rationale and Clinical Implications. | Front Immunol | 2022 | 35572596 | PubTator, text mining | PubMed |
| Inborn Errors of the Immune System Associated With Atopy. | Front Immunol | 2022 | 35572516 | PubTator, text mining | PubMed |
| DNA Damage, Defective DNA Repair, and Neurodegeneration in Amyotrophic Lateral Sclerosis. | Front Aging Neurosci | 2022 | 35572138 | PubTator, text mining | PubMed |
| Novel Therapeutic Approaches with DNA Damage Response Inhibitors for Melanoma Treatment. | Cells | 2022 | 35563772 | PubTator, text mining | PubMed |
| DNA Double-Strand Breaks as Pathogenic Lesions in Neurological Disorders. | Int J Mol Sci | 2022 | 35563044 | PubTator, text mining | PubMed |
| OX40 and 4-1BB delineate distinct immune profiles in sarcoma. | Oncoimmunology | 2022 | 35558159 | PubTator, text mining | PubMed |
| Role of EMT in the DNA damage response, double-strand break repair pathway choice and its implications in cancer treatment. | Cancer Sci | 2022 | 35534984 | PubTator, text mining | PubMed |
| Targeting double-strand break indel byproducts with secondary guide RNAs improves Cas9 HDR-mediated genome editing efficiencies. | Nat Commun | 2022 | 35534455 | PubTator, text mining | PubMed |
| Joining the PARty: PARP Regulation of KDM5A during DNA Repair (and Transcription?). | Bioessays | 2022 | 35532219 | PubTator, text mining | PubMed |
| The Roles of Non-Coding RNAs in Radiotherapy of Gastrointestinal Carcinoma. | Front Cell Dev Biol | 2022 | 35517505 | PubTator, text mining | PubMed |
| Walking a tightrope: The complex balancing act of R-loops in genome stability. | Mol Cell | 2022 | 35508167 | PubTator, text mining | PubMed |
| miR-6077 promotes cisplatin/pemetrexed resistance in lung adenocarcinoma via CDKN1A/cell cycle arrest and KEAP1/ferroptosis pathways. | Mol Ther Nucleic Acids | 2022 | 35505963 | PubTator, text mining | PubMed |
| Genetic Testing in Egyptian Patients with Inborn Errors of Immunity: a Single-Center Experience. | J Clin Immunol | 2022 | 35482138 | PubTator, text mining | PubMed |
| BCL-3 loss sensitises colorectal cancer cells to DNA damage by targeting homologous recombination. | DNA Repair (Amst) | 2022 | 35468497 | PubTator, text mining | PubMed |
| Recent Advances in the Development of Non-PIKKs Targeting Small Molecule Inhibitors of DNA Double-Strand Break Repair. | Front Oncol | 2022 | 35463312 | PubTator, text mining | PubMed |
| Impact of DNA damage response defects in cancer cells on response to immunotherapy and radiotherapy. | J Med Imaging Radiat Oncol | 2022 | 35460184 | PubTator, text mining | PubMed |
| Nanoconjugate Synthesis of Elaeocarpus ganitrus and the Assessment of Its Antimicrobial and Antiproliferative Properties. | Molecules | 2022 | 35458641 | PubTator, text mining | PubMed |
| Development and Evolution of DNA-Dependent Protein Kinase Inhibitors toward Cancer Therapy. | Int J Mol Sci | 2022 | 35457081 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3981/papers?page=29